Serial 97697661

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 30 Nov 2022 filing date already counts against anyone who files later.

Record

Serial number

97697661

Mark type

Design / logo

Filed

30 Nov 2022

Published for opposition

09 Dec 2025

Attorney of record

David P. Johnson

Goods and services

• Class 009 — Scientific and electric apparatus: Downloadable virtual goods, namely, computer programs featuring computer software for designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds, performing pharmaceutical research and development, performing scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments, for use in contract research services in support of scientific research and development of pharmaceutical preparations, for providing technical consultancy and services in relation to technical research in the field of pharmaceuticals, for use in consultancy in relation to scientific research in the field of pharmaceuticals, for providing medical research and scientific research information in the field of medicine and pharmaceuticals, for use in drug discovery services, for use in drug use discovery services, for use in scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, and conducting and evaluating clinical trials, all for use in the metaverse, online, and in online virtual worlds
• Class 035 — Advertising and business services: Virtual retail store services featuring virtual computer software for use in designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds, performing pharmaceutical research and development services, performing scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments, for use in contract research services in support of scientific research and development of pharmaceutical preparations, for providing technical consultancy and services in relation to technical research in the field of pharmaceuticals, for use in consultancy in relation to scientific research in the field of pharmaceuticals, for providing medical research and scientific research information in the field of medicine and pharmaceuticals, for use in drug discovery services, for use in drug use discovery services, for use in scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, and conducting and evaluating clinical trials; On-line retail store services featuring computer software for use in designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds, performing pharmaceutical research and development, performing scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments, for use in contract research services in support of scientific research and development of pharmaceutical preparations, for providing technical consultancy and services in relation to technical research in the field of pharmaceuticals, for use in consultancy in relation to scientific research in the field of pharmaceuticals, for providing medical research and scientific research information in the field of medicine and pharmaceuticals, for use in drug discovery services, for use in drug use discovery services, for use in scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, and conducting and evaluating clinical trials
• Class 042 — Scientific and technological services: Providing temporary use of online, non-downloadable computer software for use in designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyze data, and developing pharmaceutical products and chemical compounds, performing pharmaceutical research and development, performing scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments, for use in contract research services in support of scientific research and development of pharmaceutical preparations, for providing technical consultancy and services in relation to technical research in the field of pharmaceuticals, for providing consultancy in relation to scientific research in the field of pharmaceuticals, for providing medical research and scientific research information in the field of medicine and pharmaceuticals, for use in drug discovery services, for use in drug use discovery services, for use in scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, and conducting and evaluating clinical trials

Owner

• Recursion Pharmaceuticals, Inc., Salt Lake City, UT, US
• Recursion Pharmaceuticals, Inc., Salt Lake City, UT, US

Prosecution history

• 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 09 Dec 2025 — PUBLISHED FOR OPPOSITION
• 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 10 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 27 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 26 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 26 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 12 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 12 Jul 2025 — NON-FINAL ACTION E-MAILED
• 12 Jul 2025 — NON-FINAL ACTION WRITTEN
• 14 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 14 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 14 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 15 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED